As of today (2024-04-19), Compass Pathways's share price is $8.41.
Compass Pathways's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.99. Hence, Compass Pathways's Price-to-Operating-Cash-Flow Ratio for today is .
The historical rank and industry rank for Compass Pathways's Price-to-Operating-Cash-Flow or its related term are showing as below:
Compass Pathways's Cash Flow from Operations per share for the
three
months ended in Dec. 2023 was $-0.45.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.99.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 7.80% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -29.40% per year.
During the past 6 years, Compass Pathways's highest 3-Year average Operating Cash Flow per Share Growth Rate was 7.80% per year. The lowest was -44.70% per year. And the median was -43.90% per year.
Compass Pathways Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Compass Pathways's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
|
Compass Pathways Annual Data
|
|
Trend |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
|
- |
- |
- |
- |
- |
|
Compass Pathways Quarterly Data
|
|
Dec18 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
- |
- |
- |
- |
Competitive Comparison
For the Medical Care Facilities subindustry, Compass Pathways's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Compass Pathways Price-to-Operating-Cash-Flow Distribution
For the Healthcare Providers & Services industry and Healthcare sector, Compass Pathways's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Compass Pathways's Price-to-Operating-Cash-Flow falls into.
Compass Pathways Price-to-Operating-Cash-Flow Calculation
Compass Pathways's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 8.41 | / | -1.986 |
| = | |
Compass Pathways's Share Price of today is $8.41.
Compass Pathways's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.99.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Compass Pathways (Compass Pathways) Business Description
Traded in Other Exchanges
Address
33 Broadwick Street, London, GBR, W1F 0DQ
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
Executives
| Ekaterina Malievskaia |
officer: Chief Innovation Officer |
C/O COMPASS PATHWAYS PLC, 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE X0 WA14 2DT |
| George Jay Goldsmith |
director, 10 percent owner, officer: Chief Executive Officer |
C/O COMPASS PATHWAYS PLC, 1 ASHLEY ROAD, 3RD FLOOR, ALTRINCHAM, CHESHIRE X0 WA14 2DT |
| Mary-rose Hughes |
officer: Interim CFO |
C/O COMPASS PATHWAYS PLC, 33 BROADWICK STREET, LONDON X0 W1F0DQ |
| Daphne Karydas |
director |
35 GATEHOUSE DRIVE, BUILDING D, FLOOR 3, WALTHAM MA 02451 |
| Kabir Nath |
director, officer: Chief Executive Officer |
C/O COMPASS PATHWAYS PLC, 33 BROADWICK STREET, LONDON X0 W1F 0DQ |
| Annalisa Jenkins |
director |
C/O ARDELYX, INC., 34715 ARDENWOOD BLVD, SUITE 100, FREMONT CA 94555 |
| David Y Norton |
director |
8 GREENHOLM STREET, APT C, PRINCETON NJ 08540 |
| Matthew A Owens |
officer: General Counsel & CLO |
1900 POLARIS PARKWAY, COLUMBUS OH 43240 |
| Atai Life Sciences Ag |
10 percent owner |
KRAUSENSTRASSE 9-10, BERLIN 2M 10117 |
| Atai Life Sciences N.v. |
10 percent owner |
524 BROADWAY, NEW YORK NY 10013 |
| Linda Mcgoldrick |
director |
C/O AVADIM HEALTH, INC., 81 THOMPSON STREET, ASHEVILLE NC 28803 |
| Jason Camm |
director |
C/O ATAI LIFE SCIENCES N.V., 180 VARICK STREET, NEW YORK NY 10014 |
| Robert Mcquade |
director |
C/O COMPASS PATHWAYS PLC, 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE X0 WA14 2DT |
| Michael Falvey |
officer: Chief Financial Officer |
C/O KARYOPHARM THERAPEUTICS INC., 85 WELLS AVENUE, 2ND FLOOR, NEWTON MA 02459 |
| Guy Goodwin |
officer: Chief Medical Officer |
C/O COMPASS PATHWAYS PLC, 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE X0 WA14 2DT |
Compass Pathways (Compass Pathways) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CMPS has been successfully added to your